Abliva participates in World Mitochondrial Disease Week through videos that will be focused on increasing the understanding of the community to rare disease development, and more specifically to the development of new therapies for primary mitochondrial diseases (PMDs). Over the week we will highlight the huge unmet medical need in the area and discuss Abliva’s own efforts to treat mitochondrial disease patients with our two clinical stage compounds.
World Mitochondrial Disease Week is an initiative of International Mito Patients (IMP). The purpose of the World Mitochondrial Disease Week is to raise awareness of mitochondrial disease (mito) on a global scale through educational, fundraising and advocacy activities. This year on 19 - 25 September.